Page last updated: 2024-11-01

ofloxacin and Overweight

ofloxacin has been researched along with Overweight in 2 studies

Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Overweight: A status with BODY WEIGHT that is above certain standards. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (ADIPOSE TISSUE), hence overweight does not equal over fat.

Research Excerpts

ExcerptRelevanceReference
"This is the first study to show a positive association of enrofloxacin internal exposure with overweight or obesity risk in children, demonstrating that more attention should be given to the usage and disposal of fluoroquinolones to safeguard children's health."4.12Association between fluoroquinolone exposure and children's growth and development: A multisite biomonitoring-based study in northern China. ( Gao, M; Li, H; Li, W; Pan, X; Shan, L; Tian, H; Wang, J, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Shan, L1
Gao, M1
Pan, X1
Li, W1
Wang, J1
Li, H1
Tian, H1
Lloret-Linares, C1
Mouly, S1
Hoang-Nguyen, DT1
Evans, J1
Raskine, L1
Lopes, A1
Cambau, E1
Bergmann, JF1
Sellier, P1

Other Studies

2 other studies available for ofloxacin and Overweight

ArticleYear
Association between fluoroquinolone exposure and children's growth and development: A multisite biomonitoring-based study in northern China.
    Environmental research, 2022, Volume: 214, Issue:Pt 2

    Topics: Animals; Anti-Bacterial Agents; Biological Monitoring; Child; China; Ciprofloxacin; Enrofloxacin; Fl

2022
Inadequate therapeutic response to a recommended antituberculosis fixed-dose combination regimen in an overweight patient with Mycobacterium bovis infection.
    The Annals of pharmacotherapy, 2013, Volume: 47, Issue:1

    Topics: Adult; Antitubercular Agents; Drug Combinations; Drug Monitoring; Drug Therapy, Combination; Humans;

2013